Module 1 Discussion

The discussion question for this module is a series
of questions related to a case study found in Chapter 1 of the text. Please
answer all three questions (found below) in your initial response.

Chapter 1 (pp 7-15): CASE STUDY—GROUP HEALTH
EAST (GHE)

  • 100,000-member
    managed care organization
  • Mixed
    model
  • 55-year-old
    administrator (Mr. Jones)
  • Two
    large multi-specialty groups, each with a separate clinic
  • 500
    individual MDs in community
  • Affiliated
    with two major hospitals in Boston
  • Each
    clinic maintains a functional design
  • Two
    divisions (support services and clinical services)
  • Considering
    moving to a “matrix model”

Initial Discussion Questions:

  1. What
    are the advantages and disadvantages of a matrix model for GHE in terms of
    direct and indirect costs, as well as benefits such as improved
    coordination?
  2. How
    many product lines should the organization identify?
  3. How
    should the organization determine which product lines ought to maintain
    separate identities as part of the matrix design?

Be sure in your initial response you support your
findings and post with at least two quality, primary sources,
which may include you textbook. Cite and reference your sources.
(write 5-6 sentence summaries for each question).

Module 2 Discussion

The discussion question for this module is a series
of questions related to a case study found in Chapter 3 of the text. Please
answer all three questions (found below) in your initial response.

Chapter 3: CASE STUDY (3.2)—Breast Cancer Screening
In Case Study 3.2 in the text, Pisano and colleagues (2006) compared the
performance of digital to film mammography for breast cancer screening. Now
assume that the sensitivity and specificity of digital mammography is 85% and
95% respectively, the sensitivity and specificity of film mammography is 55%
and 85% respectively, and that 0.03% of women below the age of 50 have breast
cancer, and 12% of symptomatic women have breast cancer.

Initial Discussion Questions:

  1. How
    successful is film mammography in identifying women with breast cancer, or
    ruling out the disease in women without breast cancer?
  2. Are
    there any recent advances (previous 5 years) that could improve the
    success rates? If so, please explain what they are.

Be sure in your initial response you support your
findings and post with at least two quality, primary sources,
which may include you textbook. Cite and reference your sources.
(write 5-6 sentence summaries for each question).

Module 3 Discussion

The discussion question for this module is a series
of questions related to a case study found in Chapter 3 of the text. Please
answer all three questions (found below) in your initial response.

Chapter 5: CASE STUDY (5.3)—Inpatient Quality of Care Indicators for
Bluegrass Hospital

Suppose that the Kentucky Hospital Association (KHA) decided to provide a
service to its member hospitals by using the inpatient claims database to
calculate inpatient quality of care indicators for each
hospital. They provide a report to each hospital comparing them to national
norms. Table 5.5 presents some of these indicators for Bluegrass Hospital, a
fictional 200-bed hospital located in Central Kentucky. Upon receiving this
report, Bluegrass Hospital organizes a quality improvement (QI) team to
evaluate and develop recommendations.

Initial Discussion Questions:

  1. From
    an evaluation of the report card only, Bluegrass Hospital would seem to be
    deficient in which areas? Why?
  2. Since
    the report is based on an evaluation of administrative data, what should
    the first course of action be? Why?

Research an inpatient quality of care indicator and
provide a 5-6 sentence summary of an article from peer
reviewed literature that describes how performance on that indicator can
be improved upon.

Module 4 Discussion

Clinical, research and managerial epidemiologists
deal in risk. Risk is the chance that a person may or may not develop the
condition, with or without exposure, in a defined time period. There
is more than one type of risk.

Type of Risk

Absolute risk(incidence, prevalence)

Relative risk (RR)(Odds Ratio)

Attributable
risk/fraction

Risk Objective

To
determine the rates of disease by person, place and time

To
identify the risk factors for the disease

To
develop approaches for disease prevention

Example

Birth/death
rates are absolute!

What
are the odds?

Increase/decrease
in incidence/proportion?

  1. What
    do we know about the absolute, relative risk and attributable risk of
    smoking and lung cancer?
  2. How
    may this knowledge help in private and public health epidemiology?

Be sure in your initial response to provide at
least two examples from peer reviewed literature that expound upon
this relationship (write 5-6 sentence summaries for each article).

Module 5 Discussion

The cost effectiveness analysis (CEA) is one type
of a benefit analysis tool used in managerial epidemiology. Others
include cost-utility, cost-effectiveness, cost-consequence, and cost of
illness. Since medical quality and health services have a high individual
perception regarding value, different stakeholders will have different
perspectives when performing and interpreting a CEA. Different decision
makers, i.e., physicians, administrators, employers, payers, government and
other public and private officials all have varying
perspectives. Therefore, it is the common perspective that is generally
most useful when making comparisons among the various interpretations of the
CEA or other cost/benefit analysis results and outcomes.

  1. Where
    does the CEA fit into public health and clinical epidemiological
    research, as well as, health services research?
  2. What
    are some examples and characteristics of medical cost and effectiveness
    measures?

Be sure in your initial response to provide at
least two examples from peer reviewed literature that further clarify
or illustrate your response (write 5-6 sentence summaries for each article).

Module 6 Discussion

How research is designed is important to its
validity. In research, and particularly government funded research, the
Institutional Review Board is the authority on requirements for research
design.

DHHS, Institutional Review Board
Guidebook. Chapter 4: Considerations of Research Design

A. Introduction

F. Case-Control
Studies

B. Observation

G. Prospective
Studies

C. Record Reviews
and Historical Studies

H. Clinical
Trials

D. Surveys,
Questionnaires, and Interviews

I. Identification
and Recruitment of Subjects

E. Epidemiologic
Studies

J. Assignment of
Subjects to Experimental and Control Groups

Four common research designs used in
epidemiological studies are cohort, case control, longitudinal, and
cross-sectional studies. However, there are also prospective and
retrospective, quantitative, qualitative and quasi (mixed) research
designs. Data is what drives medical research and its
design. Medical research drives scientific findings that ultimately
result in improving human health. All of the various research study
designs that fall into either descriptive or analytical epidemiology.

All research studies fall into either descriptive or analytical
epidemiology.

  1. What
    are those study designs and how are they defined?
  2. What
    are the strengths and weaknesses of each of the designs you have
    defined?

Be sure in your initial response to provide at
least two examples from peer reviewed literature that further clarify
or illustrate your response (write 5-6 sentence summaries for each article).

Module 7 Discussion

In last week’s discussion, we looked at types of
research designs. This week, we will look at requirements of designs
using real people, i.e., the clinical trials.

Human subjects protections update

Office for Human Research Protections
(OHRP)

  1. There
    are two types of clinical studies, i.e., clinical trials and observational
    studies. How do they differ and provide examples of each?
  2. Who
    can participate in a clinical study and what is the process to protect
    them from harm?

Be sure in your initial response to provide at
least two examples from peer reviewed literature that helps to
support your position (write 5-6 sentence summaries for each article).

Module 8 Discussion

Disease may be classified as
acute, subacute or chronic. It may be emerging or reemerging.

  1. Why is it a challenge in
    defining diseases as either totally chronic or totally infectious
    (acute) in nature?
  2. What are examples of
    emerging and reemerging diseases? Would HIV be considered an
    emerging or reemerging?

Be sure in your initial response to provide at
least two examples from peer reviewed literature that helps to
support your position (write 5-6 sentence summaries for each article).